Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

Elevated fat levels in your liver can raise your chances of developing serious health issues, including diabetes, ...

He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...

Vimseltinib is now an FDA-approved treatment for patients with tenosynovial giant cell tumor, based on findings from the ...